1. Home
  2. MLTX vs ENVA Comparison

MLTX vs ENVA Comparison

Compare MLTX & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • ENVA
  • Stock Information
  • Founded
  • MLTX 2021
  • ENVA 2011
  • Country
  • MLTX Switzerland
  • ENVA United States
  • Employees
  • MLTX N/A
  • ENVA N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • ENVA Finance: Consumer Services
  • Sector
  • MLTX Health Care
  • ENVA Finance
  • Exchange
  • MLTX Nasdaq
  • ENVA Nasdaq
  • Market Cap
  • MLTX 2.8B
  • ENVA 2.7B
  • IPO Year
  • MLTX N/A
  • ENVA N/A
  • Fundamental
  • Price
  • MLTX $51.18
  • ENVA $123.11
  • Analyst Decision
  • MLTX Strong Buy
  • ENVA Strong Buy
  • Analyst Count
  • MLTX 7
  • ENVA 6
  • Target Price
  • MLTX $74.83
  • ENVA $126.33
  • AVG Volume (30 Days)
  • MLTX 732.8K
  • ENVA 281.1K
  • Earning Date
  • MLTX 11-06-2025
  • ENVA 10-21-2025
  • Dividend Yield
  • MLTX N/A
  • ENVA N/A
  • EPS Growth
  • MLTX N/A
  • ENVA 57.71
  • EPS
  • MLTX N/A
  • ENVA 9.37
  • Revenue
  • MLTX N/A
  • ENVA $1,363,816,000.00
  • Revenue This Year
  • MLTX N/A
  • ENVA $161.82
  • Revenue Next Year
  • MLTX N/A
  • ENVA $15.63
  • P/E Ratio
  • MLTX N/A
  • ENVA $13.14
  • Revenue Growth
  • MLTX N/A
  • ENVA 21.96
  • 52 Week Low
  • MLTX $31.42
  • ENVA $79.41
  • 52 Week High
  • MLTX $61.87
  • ENVA $128.52
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 38.79
  • ENVA 64.00
  • Support Level
  • MLTX $51.45
  • ENVA $114.30
  • Resistance Level
  • MLTX $61.30
  • ENVA $117.78
  • Average True Range (ATR)
  • MLTX 2.88
  • ENVA 3.38
  • MACD
  • MLTX -0.85
  • ENVA -0.06
  • Stochastic Oscillator
  • MLTX 3.08
  • ENVA 61.63

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: